Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM for COVID-19 Prevention in Hong Kong
NCT04668222Phase 2Unknown
- Sponsor
- The University of Hong Kong
- Start
- Apr 2021
- Primary completion
- Nov 2022
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yupingfeng, Xiang Sha Liu Jun Zi Decoction, liuwei dihuang wan in coronavirus disease 2019 (COVID-19), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
yupingfengXiang Sha Liu Jun Zi Decoctionliuwei dihuang wan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04668222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04668222.